Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma

Practical Radiation Oncology

Volumn 3, Issue 4, 2013, Pages

  Tait, Lauren M ^a   Meyer, Joshua E ^b   McSpadden, Erin ^a   Cheng, Jonathan D ^b   Baciewicz, Frank A ^a   Meropol, Neal J ^c   Cohen, Steven J ^b   Wozniak, Antoinette J ^a   Choi, Minsig ^a   Konski, Andre A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; INSULIN; OXALIPLATIN; PACLITAXEL;

ADULT; AGE; ANGIOPLASTY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOMA; EXTRACORPOREAL CIRCULATION; FEMALE; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RETROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SURVIVAL TIME;

EID: 84884351693     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2013.02.001     Document Type: Article

References (21)

1. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994, 12:447-453.
2. Gagliardi G., Lax I., Ottolenghi A., Rutqvist L.E. Long-term cardiac mortality after radiotherapy of breast cancer-application of the relative seriality model. Br J Radiol 1996, 69:839-846.
3. Paszat L.F., Mackillop W.J., Groome P.A., Schulze K., Holowaty E. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999, 43:755-762.
4. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an over- view of the randomised trials. Lancet 2005, 366:2087-2106.
5. Darby S.C., McGale P., Taylor C.W., Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005, 6:557-565.
6. Bouillon K., Haddy N., Delaloge S., et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol 2011, 57:445-452.
7. Carmel R.J., Kaplan H.S. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumour eradication, and complications. Cancer 1976, 37:2813-2825.
8. Gustavsson A., Eskilsson J., Landberg T., et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol 1990, 1:355-363.
9. Cosset J.M., Henry-Amar M., Pellae-Cosset B., et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys 1991, 21:447-449.
10. Hancock S.L., Tucker M.A., Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. J Am Med Assoc 1993, 270:1949-1955.
11. Glanzmann C., Kaufmann P., Jenni R., Hess O.M., Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1998, 46:51-62.
12. Eriksson F., Gagliardi G., Liedberg A., et al. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol 2000, 55:153-162.
13. Aleman B.M., van den Belt-Dusebout A.W., Klokman W.J., Van't Veer M.B., Bartelink H., van Leeuwen F.E. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003, 21:3431-3439.
14. Milano M.T., Constine L.S., Okunieff P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007, 17:131-140.
15. Martel M.K., Sahijdak W.M., Ten Haken R.K., Kessler M.L., Turrisi A.T. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 1998, 40:155-161.
16. Wei X., Liu H.H., Tucker S.L., et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 2008, 70:707-714.
17. Tripp P., Malhotra H.K., Javle M., et al. Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes. Dis Esophagus 2005, 18:400-405.
18. Mukherjee S., Aston D., Minett M., Brewster A.E., Crosby T.D.L. The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers. Clin Oncol (R Coll Radiol) 2003, 15:115-120.
19. Bentzen S.M., Constine L.S., Deasy J.O., et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010, 76(Suppl. 3):S3-S9.
20. Shapiro C.L., Hardenbergh P.H., Gelman R., et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 1998, 16:3493-3501.
21. Hardenbergh P.H., Munley M.T., Bentel G.C., et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 2001, 49:1023-1028.